<p><strong>雷克兰医疗工业</strong>（NASDAQ:LAKE）的股价在过去一个月表现非常糟糕，下降了 43%。对于任何长期股东来说，过去一个月结束了这一年令人遗忘的时光，锁定了 67% 的股价下跌。</p>
<p>尽管其股价大幅下跌，但你仍然可以对雷克兰医疗工业的市销率（P/S）为 0.4 倍感到无所谓，因为美国奢侈品行业的中位市销率也接近 0.7 倍。虽然这可能不会引起任何关注，但如果市销率没有得到合理解释，投资者可能会错过潜在的机会或忽视即将到来的失望。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
<p>查看我们对雷克兰医疗工业的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/283893-ps-multiple-vs-industry-1-dark-2/1767186830740?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/283893-ps-multiple-vs-industry-1-dark-2/1767186830740"/></p>
<p>NasdaqGM:LAKE 市销率与行业对比 2025 年 12 月 31 日</p>
<h3>雷克兰医疗工业的表现如何</h3>
<p>最近一段时间对雷克兰医疗工业来说是有利的，因为其收入增长速度超过了大多数其他公司。也许市场预计这种表现水平会减弱，从而使市销率无法飙升。如果不是，那么现有股东有理由对股价未来的走势感到乐观。</p>
<p>想要了解分析师对公司的完整估计吗？那么我们对雷克兰医疗工业的 <strong>免费</strong> 报告将帮助你揭示未来的趋势。</p>
<h2>收入增长指标对市销率的启示是什么？</h2>
<p>为了证明其市销率的合理性，雷克兰医疗工业需要产生与行业相似的增长。</p>
<p>回顾过去一年，公司营收实现了 27% 的显著增长。令人欣慰的是，得益于过去 12 个月的增长，收入总计也比三年前增长了 75%。因此，我们可以首先确认公司在这段时间内在收入增长方面做得非常出色。</p>
<p>展望未来，根据四位分析师的预测，预计收入将在未来一年内增长 7.9%。这将显著高于更广泛行业的 5.6% 增长预测。</p>
<p>考虑到这一点，我们发现雷克兰医疗工业的市销率与其行业同行密切匹配。这可能是因为大多数投资者并不相信公司能够实现未来的增长预期。</p>
<h2>雷克兰医疗工业的市销率对投资者意味着什么？</h2>
<p>随着股价大幅下跌，雷克兰医疗工业的市销率看起来与其他奢侈品行业相符。然而，仅仅使用市销率来判断是否应该出售你的股票并不明智，但它可以作为公司未来前景的实用指南。</p>
<p>尽管收入增长数据令人振奋，超过了行业水平，但雷克兰医疗工业的市销率并不是我们所期待的。也许收入预测的不确定性是导致市销率与行业其他公司保持一致的原因。这种不确定性似乎反映在股价上，尽管相对稳定，但考虑到收入预测，股价本可以更高。</p>
<p>话虽如此，请注意 <strong>雷克兰医疗工业在我们的投资分析中显示出 3 个警告信号</strong>，其中 1 个信号有些不愉快。</p>
<p>如果你对盈利能力强的公司感兴趣，那么你会想查看这份 <strong>免费</strong> 的有趣公司名单，这些公司交易的市盈率较低（但已证明能够增长收益）。</p>
<p>国防和灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达服务，随时随地。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

雷克兰医疗工业

<p>Lakeland Industries, Inc.（纳斯达克代码：LAKE）在过去一个月的股价大幅下跌了 43%，一年内累计下跌了 67%。尽管如此，该公司的市销率（P/S）为 0.4 倍，接近行业中位数 0.7 倍。公司经历了强劲的收入增长，过去一年增长了 27%，预计明年将增长 7.9%，超过行业平均水平。然而，未来增长预期的不确定性可能影响了其市销率，与行业同行保持一致。投资者应保持谨慎，因为投资分析中存在警示信号</p>

<p>The <strong>Lakeland Industries, Inc.</strong> (NASDAQ:LAKE) share price has fared very poorly over the last month, falling by a substantial 43%. For any long-term shareholders, the last month ends a year to forget by locking in a 67% share price decline.</p>
<div class="lb-trans"><p><strong>雷克兰医疗工业</strong>（NASDAQ:LAKE）的股价在过去一个月表现非常糟糕，下降了 43%。对于任何长期股东来说，过去一个月结束了这一年令人遗忘的时光，锁定了 67% 的股价下跌。</p>
</div><p>Although its price has dipped substantially, you could still be forgiven for feeling indifferent about Lakeland Industries' P/S ratio of 0.4x, since the median price-to-sales (or &#34;P/S&#34;) ratio for the Luxury industry in the United States is also close to 0.7x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.</p>
<div class="lb-trans"><p>尽管其股价大幅下跌，但你仍然可以对雷克兰医疗工业的市销率（P/S）为 0.4 倍感到无所谓，因为美国奢侈品行业的中位市销率也接近 0.7 倍。虽然这可能不会引起任何关注，但如果市销率没有得到合理解释，投资者可能会错过潜在的机会或忽视即将到来的失望。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前入场。</p>
</div><p>See our latest analysis for Lakeland Industries</p>
<div class="lb-trans"><p>查看我们对雷克兰医疗工业的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/283893-ps-multiple-vs-industry-1-dark-2/1767186830740" alt="" original-src="https://images.simplywall.st/asset/chart/283893-ps-multiple-vs-industry-1-dark-2/1767186830740"/></p>
<p>NasdaqGM:LAKE Price to Sales Ratio vs Industry December 31st 2025</p>
<div class="lb-trans"><p>NasdaqGM:LAKE 市销率与行业对比 2025 年 12 月 31 日</p>
</div><h3>How Lakeland Industries Has Been Performing</h3>
<div class="lb-trans"><h3>雷克兰医疗工业的表现如何</h3>
</div><p>Recent times have been advantageous for Lakeland Industries as its revenues have been rising faster than most other companies. Perhaps the market is expecting this level of performance to taper off, keeping the P/S from soaring. If not, then existing shareholders have reason to be feeling optimistic about the future direction of the share price.</p>
<div class="lb-trans"><p>最近一段时间对雷克兰医疗工业来说是有利的，因为其收入增长速度超过了大多数其他公司。也许市场预计这种表现水平会减弱，从而使市销率无法飙升。如果不是，那么现有股东有理由对股价未来的走势感到乐观。</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on Lakeland Industries will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析师对公司的完整估计吗？那么我们对雷克兰医疗工业的 <strong>免费</strong> 报告将帮助你揭示未来的趋势。</p>
</div><h2>What Are Revenue Growth Metrics Telling Us About The P/S?</h2>
<div class="lb-trans"><h2>收入增长指标对市销率的启示是什么？</h2>
</div><p>In order to justify its P/S ratio, Lakeland Industries would need to produce growth that's similar to the industry.</p>
<div class="lb-trans"><p>为了证明其市销率的合理性，雷克兰医疗工业需要产生与行业相似的增长。</p>
</div><p>Retrospectively, the last year delivered an exceptional 27% gain to the company's top line. Pleasingly, revenue has also lifted 75% in aggregate from three years ago, thanks to the last 12 months of growth. So we can start by confirming that the company has done a great job of growing revenue over that time.</p>
<div class="lb-trans"><p>回顾过去一年，公司营收实现了 27% 的显著增长。令人欣慰的是，得益于过去 12 个月的增长，收入总计也比三年前增长了 75%。因此，我们可以首先确认公司在这段时间内在收入增长方面做得非常出色。</p>
</div><p>Looking ahead now, revenue is anticipated to climb by 7.9% during the coming year according to the four analysts following the company. That's shaping up to be materially higher than the 5.6% growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未来，根据四位分析师的预测，预计收入将在未来一年内增长 7.9%。这将显著高于更广泛行业的 5.6% 增长预测。</p>
</div><p>With this in consideration, we find it intriguing that Lakeland Industries' P/S is closely matching its industry peers. It may be that most investors aren't convinced the company can achieve future growth expectations.</p>
<div class="lb-trans"><p>考虑到这一点，我们发现雷克兰医疗工业的市销率与其行业同行密切匹配。这可能是因为大多数投资者并不相信公司能够实现未来的增长预期。</p>
</div><h2>What Does Lakeland Industries' P/S Mean For Investors?</h2>
<div class="lb-trans"><h2>雷克兰医疗工业的市销率对投资者意味着什么？</h2>
</div><p>With its share price dropping off a cliff, the P/S for Lakeland Industries looks to be in line with the rest of the Luxury industry. Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>随着股价大幅下跌，雷克兰医疗工业的市销率看起来与其他奢侈品行业相符。然而，仅仅使用市销率来判断是否应该出售你的股票并不明智，但它可以作为公司未来前景的实用指南。</p>
</div><p>Despite enticing revenue growth figures that outpace the industry, Lakeland Industries' P/S isn't quite what we'd expect. Perhaps uncertainty in the revenue forecasts are what's keeping the P/S ratio consistent with the rest of the industry. This uncertainty seems to be reflected in the share price which, while stable, could be higher given the revenue forecasts.</p>
<div class="lb-trans"><p>尽管收入增长数据令人振奋，超过了行业水平，但雷克兰医疗工业的市销率并不是我们所期待的。也许收入预测的不确定性是导致市销率与行业其他公司保持一致的原因。这种不确定性似乎反映在股价上，尽管相对稳定，但考虑到收入预测，股价本可以更高。</p>
</div><p>Having said that, be aware <strong>Lakeland Industries is showing 3 warning signs</strong> in our investment analysis, and 1 of those is a bit unpleasant.</p>
<div class="lb-trans"><p>话虽如此，请注意 <strong>雷克兰医疗工业在我们的投资分析中显示出 3 个警告信号</strong>，其中 1 个信号有些不愉快。</p>
</div><p>If strong companies turning a profit tickle your fancy, then you'll want to check out this <strong>free</strong> list of interesting companies that trade on a low P/E (but have proven they can grow earnings).</p>
<div class="lb-trans"><p>如果你对盈利能力强的公司感兴趣，那么你会想查看这份 <strong>免费</strong> 的有趣公司名单，这些公司交易的市盈率较低（但已证明能够增长收益）。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>国防和灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔楼，在 30 分钟内提供 5G、ISR 和雷达服务，随时随地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

雷克兰医疗工业公司（NASDAQ:LAKE）在股价暴跌 43% 后，可能并不像表面上看起来那样被错误定价